Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy DOI Creative Commons

Elaine Julian,

Tom Belleman, Maria João Garcia

и другие.

Journal of Market Access & Health Policy, Год журнала: 2025, Номер 13(1), С. 6 - 6

Опубликована: Фев. 10, 2025

We examined four potential challenges for the implementation of European Union (EU) Regulation 2021/2282 on Health Technology Assessment (EU HTAR): interaction with Medicines Agency (EMA), expert input, interface health technology assessment HTA) joint procedures those within Member States, and management conflict interest. This research aims to explore how address these in a balanced manner prioritise key actions effective collaboration context EU HTA. The methodology included pre-convention survey among relevant stakeholders as well working groups plenary ranking discussion outcomes at Access Academy (EAA) Spring Convention 2024. In survey, 65.5% respondents indicated that experts are currently not sufficiently upcoming scientific consultations clinical assessments; only 37.9% suggested HTA would accelerate national appraisal decision-making, 58.6% believed principles 'transparency' 'competency' position top priority action points identified were involvement best available expertise, early inclusive experts, strengthened dialogue, fostering political willingness/financial support States increase capacities. topics an approach interest balances transparency obligations need strengthens patient intensifies between EMA HTA, increases States.

Язык: Английский

Access in all areas? A roundup of developments in market access and health technology assessment: part 6 DOI Creative Commons

Annie Jullien Pannelay,

Ramiro Gilardino, Sreeram V Ramagopalan

и другие.

Journal of Comparative Effectiveness Research, Год журнала: 2025, Номер 14(3)

Опубликована: Фев. 19, 2025

In this update, we discuss an article covering the implementation challenges of upcoming European Union Health Technology Assessment regulation, particularly focusing on complexity population, intervention, comparator and outcomes requirements across member states; a user guide to applying generalized cost–effectiveness analysis for broader value assessment finally highlight ongoing debate surrounding National Institute Care Excellence's severity modifier implementation.

Язык: Английский

Процитировано

1
Avoiding Error and Finding the Right Balance in European Health Technology Assessments: Insights Generated by the European Access Academy DOI Creative Commons

Elaine Julian,

Tom Belleman, Maria João Garcia

и другие.

Journal of Market Access & Health Policy, Год журнала: 2025, Номер 13(1), С. 6 - 6

Опубликована: Фев. 10, 2025

We examined four potential challenges for the implementation of European Union (EU) Regulation 2021/2282 on Health Technology Assessment (EU HTAR): interaction with Medicines Agency (EMA), expert input, interface health technology assessment HTA) joint procedures those within Member States, and management conflict interest. This research aims to explore how address these in a balanced manner prioritise key actions effective collaboration context EU HTA. The methodology included pre-convention survey among relevant stakeholders as well working groups plenary ranking discussion outcomes at Access Academy (EAA) Spring Convention 2024. In survey, 65.5% respondents indicated that experts are currently not sufficiently upcoming scientific consultations clinical assessments; only 37.9% suggested HTA would accelerate national appraisal decision-making, 58.6% believed principles 'transparency' 'competency' position top priority action points identified were involvement best available expertise, early inclusive experts, strengthened dialogue, fostering political willingness/financial support States increase capacities. topics an approach interest balances transparency obligations need strengthens patient intensifies between EMA HTA, increases States.

Язык: Английский

Процитировано

0